COSG
Grand Gallery Inc.
Set alert
0.06 USD 0.00 0.00%
0.028 Day range 0.028
0.0001 52-week range 0.3639
- YTD
- +525.00%
- 1 year
- -96.88%
- Open
- 0.028
- Prev close
- 0.0625
- Mkt cap
- 1.91M
- Vol
- 100
- Avg vol
- 217
- EPS
- 20.07
- P/E
- 0.00
More statistics
- Low
- 0.028
- High
- 0.028
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 20, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Nov 22, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Aug 21, 2023 | Jun 1, 2023 | 0.00 | -0.01 | — | — |
| May 22, 2023 | Mar 1, 2023 | 0.00 | -0.01 | — | — |
News
- Cosmos Group (OTCMKTS:COSG) Share Price Crosses Above 200 Day Moving Average – Should You Sell?
- Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway
- Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion
- Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days
- Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription
- Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days
- Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
- Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
- Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
- Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
Your note
Sign in to keep a note on COSG — it syncs with the Stock Master app.